Patterns of acquired bleeding disorders in a tertiary care hospital

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 4, 2009, Pages 448-453

  Asthana, Bhushan ^a   Sharma, Prashant ^a   Ranjan, Ravi ^a   Jain, Prachi ^a   Aravindan, Ajisha ^a   Chandra Mishra, Pravas ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acquired bleeding disorders; Anticoagulants; DIC; Factor inhibitors; Hemostasis; Hepatic coagulopathy; Isolated prolonged prothrombin time

Indexed keywords

ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; LABORATORY TEST; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PROTHROMBIN TIME; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMORRHAGE; HOSPITALS; HUMANS; INCIDENCE; INDIA; INFANT; INFANT, NEWBORN; LIVER DISEASES; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 69749086448     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609334123     Document Type: Article

References (27)

1. Schaumacher HR, Rock WA, Stass SA Handbook of Hematologic Pathology. Informa HealthCare ; New York, 2000: 611-654.
2. Schmaier AH, Petruzzelli LM Hematology for the Medical Student. Lippincott Williams & Wilkins, Philadelphia, 2003. 99-104.
3. Bick RL Acquired platelet function defects. Hematol Oncol Clin North Am. 1992 ; 6 (6). 1203-1228.
4. Prentice CR Acquired coagulation disorders. Clin Haematol. 1985 ; 14 (2). 413-442.
5. Quick AJ Quick on Quick's test. N Engl J Med. 1973 ; 288 (20). 1079.
6. Dacie JV, Lewis SM Practical Haematology. 9 th ed. Edinburgh: Churchill Livingstone ; 2001.
7. Flanders MM, Crist R., Rodgers GM Comparison of five thrombin time reagents. Clin Chem. 2003 ; 49 (1). 169-172.
8. Van Cott EM, Laposata M. "Coagulation." In: Jacobs DS, Oxley DK, DeMott WR, eds. The Laboratory Test Handbook. 5 th ed. Cleveland, OH: Lexi-Comp ; 2001: 327-358.
9. Verbruggen B., Novakova I., Wessels H., Boezeman J., van den Berg M., Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost. 1995 ; 73 (2). 247-251.
10. Boudjeltia KZ, Cauchie P., Remacle C., et al. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time. BMC Biotechnol. 2002 ; 2: 8.
11. Mielke CH Jr, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 ; 34 (2). 204-215.
12. Woronzoff-Dashkoff KK The wright-giemsa stain. Secrets revealed. Clin Lab Med. 2002 ; 22 (1). 15-23.
13. British Committee for Standards in Haematology. Guidelines on oral anticoagulation: third edition. Br J Haematol. 1998 ; 101 (2). 374-387.
14. Hirsh J., Warkentin TE, Raschke R., Granger C., Ohman EM, Dalen JE Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1998 ; 114 (5 suppl). 489S - 510S.
15. Matsumoto T., Wada H., Nobori T., et al. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2005 ; 11 (4). 391-400. (Pubitemid 41546765)
16. Yu M., Nardella A., Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med. 2002 ; 28 (6). 1777-1780.
17. Pantanowitz L., Kruskall MS, Uhl L. Cryoprecipitate. Patterns of use. Am J Clin Pathol. 2003 ; 119 (6). 874-881.
18. Segal JB, Dzik WH Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005 ; 45 (9). 1413-1425.
19. Deitcher SR Interpretation of the international normalised ratio in patients with liver disease. Lancet. 2002 ; 359 (9300). 47-48.
20. Abdel-Wahab OI, Healy B., Dzik WH Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006 ; 46 (8). 1279-1285.
21. Stanworth SJ The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program. 2007 ; 2007: 179-186.
22. Holland LL, Brooks JP Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. 2006 ; 126 (1). 133-139.
23. Nathens AB Massive transfusion as a risk factor for acute lung injury: association or causation? Crit Care Med. 2006 ; 34 (5 suppl). S144 - S150.
24. Feinstein RJ, Halprin KM, Penneys NS, Taylor JR, Schenkman J. Senile purpura. Arch Dermatol. 1973 ; 108 (2). 229-232.
25. Tizard EJ, Hamilton-Ayres MJ Henoch Schonlein purpura. Arch Dis Child Educ Pract Ed. 2008 ; 93 (1). 1-8.
26. Olmedo JM, Yiannias JA, Windgassen EB, Gornet MK Scurvy: a disease almost forgotten. Int J Dermatol. 2006 ; 45 (8). 909-913.
27. Sabbà C. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost. 2005 ; 3 (10). 2201-2210.